ALK rearrangements in NSCLC have been most commonly identified in adenocarcinoma, but have also been seen in squamous cell carcinoma and lymphoepithelioma-like carcinoma[10-12]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.